Court Opinion

ID: 9375642
Source: CourtListenerOpinion
Date Created: 2023-02-28 16:01:03.769113+00
Date Added: 2024-06-11T17:17:00.820604
License: Public Domain

Case: 23-1020   Document: 25     Page: 1   Filed: 02/28/2023

           NOTE: This order is nonprecedential.

   United States Court of Appeals
       for the Federal Circuit
                 ______________________

                 GINA RUSSOMANNO,
                   Plaintiff-Appellant

                            v.

   SUNOVION PHARMACEUTICALS INC., IQVIA,
   INC., DAN DUGAN, JENNA YACKISH, TREVOR
              VOLTZ, ERIC WEEDON,
                Defendants-Appellees
               ______________________

                  2023-1020, 2023-1022
                 ______________________

     Appeals from the United States District Court for the
 District of New Jersey in Nos. 3:19-cv-05945-FLW-DEA,
 and 3:20-cv-12336-FLW-DEA, Judge Freda L. Wolfson.
                 ______________________

                     ON MOTION
                 ______________________

 PER CURIAM.
                        ORDER
    In response to this court’s January 3, 2023, order to
 show cause, IQVIA, Inc. urges dismissal of these appeals.
 Gina Russomanno opposes dismissal and moves for sum-
 mary determination.
Case: 23-1020     Document: 25      Page: 2    Filed: 02/28/2023

 2           RUSSOMANNO    v. SUNOVION PHARMACEUTICALS INC.

     Ms. Russomanno brought these employment-related
 suits against her former private employer. On the motion
 of the defendants, the United States District Court for the
 District of New Jersey dismissed. In September 2022, Ms.
 Russomanno moved to reopen, which the district court de-
 nied on September 27, 2022. Ms. Russomanno then filed
 notices of appeals that were transmitted to both this court
 and the United States Court of Appeals for the Third Cir-
 cuit.
     Ms. Russomanno’s appeals do not fall within the lim-
 ited jurisdiction that Congress granted to this court to re-
 view decisions of federal district courts under 28 U.S.C.
 § 1295(a). That jurisdiction extends only to cases arising
 under the patent laws, see 28 U.S.C. § 1295(a)(1); civil ac-
 tions on review to the district court from the United States
 Patent and Trademark Office, see § 1295(a)(4)(C); or cer-
 tain damages claims against the United States “not exceed-
 ing $10,000 in amount,” 28 U.S.C. § 1346(a)(2), see 28
 U.S.C. § 1295(a)(2). Ms. Russomanno’s cases are outside of
 that limited review authority.
     While this court may transfer a case under 28 U.S.C.
 § 1631, if it is in the interest of justice, to the court where
 “the action or appeal could have been brought at the time
 it was filed,” Ms. Russomanno has already filed an appeal
 with the Third Circuit, which has affirmed the district
 court’s dismissals. Under such circumstances, we see no
 reason to transfer.
     Accordingly,
     IT IS ORDERED THAT:
     (1) The appeals are dismissed.
     (2) All pending motions are denied as moot.
Case: 23-1020      Document: 25   Page: 3     Filed: 02/28/2023

 RUSSOMANNO     v. SUNOVION PHARMACEUTICALS INC.            3

    (3) Each side shall bear its own costs.
                                    FOR THE COURT

 February 28, 2023                  /s/ Peter R. Marksteiner
       Date                         Peter R. Marksteiner
                                    Clerk of Court